Search for: "Sanofi" Results 61 - 80 of 1,186
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Aug 2012, 2:36 pm by By PETER LATTMAN
Federal securities regulators on Tuesday charged eight people in Georgia with insider trading, saying they bought stock in a company ahead of a merger announcement after one of them learned about a pending acquisition by Sanofi-Aventis [read post]
28 Aug 2012, 2:36 pm by By PETER LATTMAN
Federal securities regulators on Tuesday charged eight people in Georgia with insider trading, saying they bought stock in a company ahead of a merger announcement after one of them learned about a pending acquisition by Sanofi-Aventis [read post]
22 Oct 2010, 3:41 pm by By ANDREW POLLACK
Seeking to fend off a hostile takeover bid by Sanofi-Aventis, the biotechnolgy company Genzyme argued strenuously that it was worth far more than the $18.5 billion that the French drug maker is offering. [read post]
28 Aug 2012, 2:36 pm by By PETER LATTMAN
Federal securities regulators on Tuesday charged eight people in Georgia with insider trading, saying they bought stock in a company ahead of a merger announcement after one of them learned about a pending acquisition by Sanofi-Aventis [read post]
6 Feb 2011, 12:25 pm by By MICHAEL J. DE LA MERCED
The two companies are in the final stages of discussions over what will likely be a $19 billion takeover of Genzyme by Sanofi-Aventis, though the talks have taken longer than expected. [read post]
2 Aug 2023, 11:05 am by Sofya Asatryan
Sanofi further argued that the Board improperly shifted the burden of persuasion from Mylan to prove that the challenged claims were unpatentable to Sanofi to defend the claims of the ’614 patent as patentable. [read post]
12 Nov 2009, 3:02 am
The top executive of French drug maker Sanofi-Aventis reached out to Boston-area researchers and biotechnology start-ups, offering "partnerships for innovation" that could range from investing in drugs to outright acquisitions, The Boston Globe reported. [read post]
8 Sep 2010, 2:37 am by By DEALBOOK
Sanofi-Aventis's chief executive Chris Viehbacher took his case for a takeover directly to Genzyme's investors in meetings in New York Tuesday, Bloomberg News reported, citing two people who attended. [read post]
23 Mar 2011, 2:44 am by By CHRIS V. NICHOLSON
The French pharmaceutical giant Sanofi-Aventis says it will issue $7 billion worth of notes to help finance its acquisition of the American biotechnology firm Genzyme. [read post]
2 Jul 2010, 4:30 am by By DEALBOOK
Sanofi-Aventis, the French drug giant, is reportedly preparing for a U.S acquisition that could be worth $20 billion or more, Bloomberg News reported. [read post]
19 Feb 2008, 1:23 am
Pharmaceutical company Sanofi-Aventis filed a complaint in Los Angeles, California District Court seeking a declaratory judgment that three medical device patents are invalid and not infringed by Sanofi's syringes. [read post]
2 Feb 2007, 12:16 pm
Despite the enthusiasm of analysts and investors, the rumored acquisition of Bristol-Myers Squibb by Paris-based Sanofi-Aventis is probably a bad idea in the long term, writes Forbes’ Matthew Herper. [read post]
10 Feb 2012, 12:39 pm
Bristol and Sanofi are not the only companies to face the threat of generic substitutes competing for valuable market share. [read post]
4 Nov 2022, 3:49 pm by admin
Sanofi, and patent enablement appeared first on PatentAssociate.com. [read post]
15 Dec 2023, 1:16 pm by FRANK VINLUAN - MEDCITY NEWS
The post Sanofi Abandons Deal For Rare Disease Drug Amid FTC’s Monopoly Concerns appeared first on Above the Law. [read post]
11 Oct 2023, 8:17 am by Kathryn Rubino
The post Sanofi Adds Biologics to Its AI Ambitions, Striking Up R&D Alliance With BioMap appeared first on Above the Law. [read post]
27 Sep 2010, 4:19 am by By DEALBOOK
Sanofi-Aventis is looking to line up additional financing as it mulls upping its bid for Genzyme, The Wall Street Journal reported. [read post]
8 Nov 2010, 11:58 am by By MICHAEL J. DE LA MERCED
Sanofi-Aventis on Monday sent a letter to Genzyme's chief executive, asking that the biotech giant not seek to block its unsolicited takeover bid by altering its board or using anti-takeover laws in its home state, Massachusetts. [read post]